| Enrolment Visit |
As scheduled with Site Investigator |
Eligibility screening and enrolment |
| Study Visit 1 |
Minimum 1 week following Enrolment Visit |
Phimosis measurement, quality of life questionnaire, Novoglan product supply and training |
| Study Visit 2 (phone) |
1 week following Study Visit 1 |
Treatment progress and adverse events |
| Study Visit 3 (phone) |
4 weeks following Study Visit 1 |
Treatment progress and adverse events |
| Final Visit |
6–8 weeks following Study Visit 1 |
Phimosis measurement, quality of life questionnaire, tolerability questionnaire, trial completion |
